NFKB1 and viral infectious disease: It's interesting to note that during viral infection, SARS-CoV-2 ORF9b is known to target the NEMO and disrupt its K63-linked polyubiquitination, which inhibits IKKα/β/γ-NF-κB signaling and subsequent interferon production [42].